CN Stock MarketDetailed Quotes
600216 Zhejiang Medicine
- 16.54
- -0.38-2.25%
Market Closed Dec 13 15:00 CST
15.91BMarket Cap16.26P/E (TTM)
16.88High16.51Low146.15KlotVolume16.81Open16.92Pre Close243.16MTurnover1.52%Turnover Ratio37.00P/E (Static)961.64MShares19.4052wk High1.54P/B15.91BFloat Cap7.8252wk Low18.61Limit Up961.63MShs Float21.43Historical High15.23Limit Down2.19%Amplitude-2.86Historical Low0.15Dividend TTM16.64Avg Price81.38KlotAsk0.91%Div YieldTTM100Lot Size61.13KlotBid
Zhejiang Medicine Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 21.04%7.11B | 11.87%4.41B | 12.01%2.25B | -3.96%7.79B | -4.04%5.88B | -4.36%3.94B | -8.07%2.01B | -11.10%8.12B | -10.10%6.12B | -10.83%4.12B |
| Operating revenue | 21.04%7.11B | 11.87%4.41B | 12.01%2.25B | -3.96%7.79B | -4.04%5.88B | -4.36%3.94B | -8.07%2.01B | -11.10%8.12B | -10.10%6.12B | -10.83%4.12B |
| Other operating revenue | ---- | -14.42%14.22M | ---- | -25.71%32.11M | ---- | -24.00%16.61M | ---- | 4.66%43.23M | ---- | 36.64%21.86M |
| Total operating cost | 8.85%6.1B | 8.39%4.01B | 12.03%2.13B | 2.67%7.68B | 1.98%5.61B | 2.83%3.7B | 0.98%1.9B | -5.68%7.48B | -7.85%5.5B | -10.40%3.6B |
| Operating cost | 9.23%4.26B | 9.25%2.85B | 13.43%1.51B | -0.91%5.27B | -0.76%3.9B | 0.63%2.61B | -2.08%1.33B | -1.51%5.32B | -1.10%3.93B | -1.32%2.59B |
| Operating tax surcharges | 26.92%67.95M | 16.64%39.15M | 26.25%20.53M | 12.26%78.43M | 17.46%53.54M | 16.94%33.57M | -11.77%16.26M | -7.06%69.86M | -16.63%45.58M | -15.35%28.7M |
| Operating expense | 12.51%849.54M | 14.57%537.17M | 6.15%288.7M | 17.41%1.05B | 6.82%755.07M | 4.35%468.87M | 16.54%271.97M | -21.15%890.51M | -24.79%706.84M | -27.04%449.32M |
| Administration expense | 22.44%378M | 11.54%221.36M | 8.77%115.12M | 3.04%445.19M | 4.75%308.72M | 4.34%198.45M | 29.22%105.84M | 0.95%432.07M | 17.48%294.71M | 17.89%190.2M |
| Financial expense | 86.13%-2.87M | 76.27%-7.94M | -82.47%2.01M | 53.94%-17.49M | 44.35%-20.69M | -195.89%-33.47M | -39.09%11.45M | -140.78%-37.97M | -171.84%-37.18M | -129.21%-11.31M |
| -Interest expense (Financial expense) | 0.80%21.45M | 4.02%14.99M | -5.59%6.8M | -14.43%28.38M | -16.13%21.28M | -13.86%14.41M | -15.50%7.2M | -16.10%33.17M | -15.32%25.38M | -14.63%16.73M |
| -Interest Income (Financial expense) | -22.67%-15.44M | -16.49%-9.47M | -89.28%-4.79M | -25.31%-16.51M | -38.29%-12.58M | -33.72%-8.13M | 20.65%-2.53M | 15.58%-13.18M | 22.96%-9.1M | 23.30%-6.08M |
| Research and development | -9.92%546.93M | -12.23%377.48M | 17.70%196.22M | 6.28%860.07M | 9.32%607.13M | 21.13%430.1M | -3.63%166.71M | 0.30%809.28M | -19.82%555.39M | -34.89%355.08M |
| Credit Impairment Loss | -98.90%191.89K | -98.79%275.24K | 78.13%-1.89M | 212.46%28.21M | 119.44%17.39M | 150.77%22.75M | 31.19%-8.63M | -197.05%-25.09M | -368.27%-89.45M | -175.53%-44.81M |
| Asset Impairment Loss | -57.35%-101.49M | -94.96%-67.11M | -92.87%-26.26M | -17.13%-137.21M | 24.35%-64.5M | 48.51%-34.42M | 33.49%-13.62M | 29.08%-117.14M | 20.06%-85.27M | 6.29%-66.85M |
| Other net revenue | -625.45%-72.39M | -387.42%-50.62M | -8,568.09%-15.98M | 307.24%267.68M | 91.93%-9.98M | 117.86%17.61M | 99.43%-184.38K | -644.15%-129.16M | -571.20%-123.72M | -673.93%-98.6M |
| Fair value change income | 24.10%-3.58M | -318.04%-11.59M | -161.57%-6.96M | 57.71%-10.1M | 81.68%-4.71M | 121.34%5.32M | 143.45%11.31M | -146.17%-23.88M | -146.48%-25.74M | -275.86%-24.91M |
| Invest income | -2,589.32%-16.22M | -529.11%-11.61M | -148.12%-1.5M | 89.26%-3.5M | -102.18%-603.06K | -59.40%2.71M | -81.75%3.12M | -178.03%-32.63M | -37.04%27.66M | -63.10%6.66M |
| -Including: Investment income associates | -76.71%-12.36M | -139.71%-10.2M | 50.16%-845.02K | -157.01%-9.78M | -480.98%-7M | -120.86%-4.25M | 4.92%-1.7M | 10.23%-3.81M | -187.33%-1.2M | -332.42%-1.93M |
| Asset deal income | -8.76%-818.04K | -1,433.67%-958.36K | -3,271.76%-849.64K | 9,876.06%330.16M | -124.88%-752.18K | -101.99%-62.49K | -100.75%-25.2K | -18.47%3.31M | -27.18%3.02M | -34.76%3.14M |
| Other revenue | 14.62%49.53M | 89.29%40.37M | 180.53%21.48M | -9.27%60.12M | -6.17%43.21M | -24.30%21.33M | 18.68%7.66M | 12.97%66.26M | -5.17%46.05M | -25.51%28.17M |
| Operating profit | 261.45%937.08M | 35.05%341.43M | -3.33%101.8M | -24.66%380.16M | -48.31%259.25M | -39.54%252.82M | -60.71%105.3M | -57.22%504.62M | -42.42%501.55M | -28.65%418.16M |
| Add:Non operating Income | -88.40%2.84M | -97.97%492.76K | 66.20%282.57K | -15.58%1.8M | 1,496.52%24.46M | 5,034.16%24.33M | 20.29%170.02K | 104.54%2.13M | 63.24%1.53M | -39.20%473.81K |
| Less:Non operating expense | -40.60%9.11M | -48.43%7.34M | -66.69%1.04M | 21.63%18.67M | 15.72%15.34M | 68.02%14.23M | 16.78%3.11M | -43.02%15.35M | -24.13%13.25M | -25.15%8.47M |
| Total profit | 246.82%930.81M | 27.26%334.59M | -1.29%101.04M | -26.07%363.28M | -45.21%268.38M | -35.90%262.92M | -61.44%102.36M | -57.40%491.39M | -42.68%489.82M | -28.74%410.16M |
| Less:Income tax cost | 96.82%172.25M | 4.36%79.22M | 18.54%21.68M | -32.84%86.48M | -33.66%87.52M | -22.42%75.91M | -63.89%18.29M | -52.12%128.77M | -21.76%131.93M | -8.23%97.86M |
| Net profit | 319.40%758.56M | 36.56%255.37M | -5.60%79.36M | -23.67%276.79M | -49.46%180.87M | -40.12%187M | -60.87%84.07M | -59.01%362.61M | -47.82%357.9M | -33.40%312.31M |
| Net profit from continuing operation | 319.40%758.56M | 36.56%255.37M | -5.60%79.36M | -23.67%276.79M | -49.46%180.87M | -40.12%187M | -60.87%84.07M | -59.01%362.61M | -47.82%357.9M | -33.40%312.31M |
| Less:Minority Profit | 24.39%-91.09M | 29.67%-59.97M | -2.74%-30.29M | 13.63%-152.85M | 4.81%-120.47M | -8.91%-85.26M | 35.49%-29.48M | -10.07%-176.96M | -95.59%-126.55M | -102.37%-78.28M |
| Net profit of parent company owners | 181.96%849.65M | 15.82%315.33M | -3.44%109.65M | -20.37%429.64M | -37.80%301.34M | -30.29%272.26M | -56.42%113.55M | -48.38%539.57M | -35.46%484.45M | -23.06%390.59M |
| Earning per share | ||||||||||
| Basic earning per share | 183.87%0.88 | 17.86%0.33 | -8.33%0.11 | -19.64%0.45 | -39.22%0.31 | -31.71%0.28 | -55.56%0.12 | -48.62%0.56 | -34.62%0.51 | -22.64%0.41 |
| Diluted earning per share | 183.87%0.88 | 17.86%0.33 | -8.33%0.11 | -19.64%0.45 | -39.22%0.31 | -31.71%0.28 | -55.56%0.12 | -48.62%0.56 | -34.62%0.51 | -22.64%0.41 |
| Other composite income | -125.03%-1.44M | -130.52%-4.26M | -413.80%-3.95M | 24.35%11.71M | 544.32%5.76M | 574.32%13.97M | 130.70%1.26M | 160.65%9.42M | 85.39%-1.3M | 49.85%-2.94M |
| Other composite income of parent company owners | -125.28%-1.39M | -130.08%-3.99M | -406.69%-3.71M | 26.64%11.04M | 444.08%5.48M | 553.90%13.26M | 131.98%1.21M | 160.53%8.72M | 80.56%-1.59M | 45.11%-2.92M |
| Other composite income of minority owners | -120.15%-55.75K | -138.90%-275.42K | -584.79%-243.61K | -4.28%669.49K | -6.91%276.67K | 3,111.54%707.99K | 115.64%50.25K | 162.24%699.42K | 144.13%297.21K | 95.72%-23.51K |
| Total composite income | 305.69%757.12M | 24.95%251.1M | -11.62%75.41M | -22.45%288.51M | -47.67%186.62M | -35.04%200.97M | -59.51%85.33M | -57.19%372.03M | -47.33%356.6M | -33.19%309.36M |
| Total composite income of parent company owners | 176.47%848.27M | 9.04%311.34M | -7.68%105.94M | -19.63%440.68M | -36.46%306.82M | -26.35%285.52M | -55.30%114.76M | -46.82%548.29M | -34.96%482.86M | -22.82%387.67M |
| Total composite income of minority owners | 24.17%-91.15M | 28.75%-60.24M | -3.74%-30.53M | 13.66%-152.18M | 4.80%-120.2M | -7.98%-84.55M | 36.05%-29.43M | -8.88%-176.26M | -93.12%-126.26M | -99.60%-78.31M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
